Search research articles
Contact Us
Filters
Showing results (141-150 of 155) with videos related to
Page
of 16
Sort By:
NPJ Genomic Medicine
|
September 6, 2022
Huntington's disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
Sergey V Lobanov, Branduff McAllister, Mia McDade-Kumar, et al.
Human Brain Mapping
|
August 2, 2016
Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease
Michael Orth, Sarah Gregory, Rachael I Scahill, et al.
Journal of Neurology
|
July 25, 2025
Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases
Steffen Halbgebauer, Veronika Klose, Badrieh Fazeli, et al.
Ebiomedicine
|
December 3, 2015
Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
Stefan Klöppel, Sarah Gregory, Elisa Scheller, et al.
Scientific Reports
|
January 3, 2025
Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases
Sára Mravinacová, Sofia Bergström, Jennie Olofsson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 6, 2020
Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with <i>C9orf72</i> hexanucleotide repeat expansion
Peggy Barschke, Patrick Oeckl, Petra Steinacker, et al.
The New England Journal of Medicine
|
May 7, 2019
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, et al.
British Journal of Clinical Pharmacology
|
September 17, 2014
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
Sigurd D Süssmuth, Salman Haider, G Bernhard Landwehrmeyer, et al.
American Journal of Human Genetics
|
March 24, 2022
Genetic modifiers of Huntington disease differentially influence motor and cognitive domains
Jong-Min Lee, Yuan Huang, Michael Orth, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 17, 2017
Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
Petra Steinacker, Federico Verde, Lubin Fang, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 155) with videos related to
Sort By:
Page
of 16
NPJ Genomic Medicine
|
September 6, 2022
Huntington's disease age at motor onset is modified by the tandem hexamer repeat in TCERG1
Sergey V Lobanov, Branduff McAllister, Mia McDade-Kumar, et al.
Human Brain Mapping
|
August 2, 2016
Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease
Michael Orth, Sarah Gregory, Rachael I Scahill, et al.
Journal of Neurology
|
July 25, 2025
Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseases
Steffen Halbgebauer, Veronika Klose, Badrieh Fazeli, et al.
Ebiomedicine
|
December 3, 2015
Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
Stefan Klöppel, Sarah Gregory, Elisa Scheller, et al.
Scientific Reports
|
January 3, 2025
Addressing inter individual variability in CSF levels of brain derived proteins across neurodegenerative diseases
Sára Mravinacová, Sofia Bergström, Jennie Olofsson, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 6, 2020
Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with <i>C9orf72</i> hexanucleotide repeat expansion
Peggy Barschke, Patrick Oeckl, Petra Steinacker, et al.
The New England Journal of Medicine
|
May 7, 2019
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J Tabrizi, Blair R Leavitt, G Bernhard Landwehrmeyer, et al.
British Journal of Clinical Pharmacology
|
September 17, 2014
An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
Sigurd D Süssmuth, Salman Haider, G Bernhard Landwehrmeyer, et al.
American Journal of Human Genetics
|
March 24, 2022
Genetic modifiers of Huntington disease differentially influence motor and cognitive domains
Jong-Min Lee, Yuan Huang, Michael Orth, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 17, 2017
Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
Petra Steinacker, Federico Verde, Lubin Fang, et al.
Page
of 16